148 related articles for article (PubMed ID: 20078969)
1. [Differential diagnosis of invasive ductal carcinoma versus invasive lobular carcinoma of breast].
Yin HF; Li T; Zhang H; Zhang S
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):663-7. PubMed ID: 20078969
[TBL] [Abstract][Full Text] [Related]
2. [Expression pattern of E-cadherin and p120-catenin in infiltrating lobular carcinoma and ductal carcinoma of the breast and its significance].
Li L; Bi XF; Xu X; Liu XY; Shen GH; Guo L; Yuan YL; Wang F; Wang MR; Yang HY
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):273-7. PubMed ID: 20510078
[TBL] [Abstract][Full Text] [Related]
3. [Expression of E-cadherin, p120catenin and 34βE12 in invasive lobular carcinoma of breast and their roles in diagnosis].
Yang GZ; Zhang XL; Li J; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):741-4. PubMed ID: 22336156
[TBL] [Abstract][Full Text] [Related]
4. The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study.
Esposito NN; Chivukula M; Dabbs DJ
Mod Pathol; 2007 Jan; 20(1):130-8. PubMed ID: 17143261
[TBL] [Abstract][Full Text] [Related]
5. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin.
Dabbs DJ; Bhargava R; Chivukula M
Am J Surg Pathol; 2007 Mar; 31(3):427-37. PubMed ID: 17325485
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
7. Pleomorphic lobular carcinoma of the breast: a morphologically and clinically distinct variant of lobular carcinoma.
Butler D; Rosa M
Arch Pathol Lab Med; 2013 Nov; 137(11):1688-92. PubMed ID: 24168512
[TBL] [Abstract][Full Text] [Related]
8. Correlation between E-cadherin and p120 expression in invasive ductal breast cancer with a lobular component and MRI findings.
El Sharouni MA; Postma EL; van Diest PJ
Virchows Arch; 2017 Dec; 471(6):707-712. PubMed ID: 28779344
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
10. Expression of DDR1 and DVL1 in invasive ductal and lobular breast carcinoma does not correlate with histological type, grade and hormone receptor status.
Ameli F; Rose IM; Masir N
Asian Pac J Cancer Prev; 2015; 16(6):2385-90. PubMed ID: 25824769
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions.
Sarrió D; Pérez-Mies B; Hardisson D; Moreno-Bueno G; Suárez A; Cano A; Martín-Pérez J; Gamallo C; Palacios J
Oncogene; 2004 Apr; 23(19):3272-83. PubMed ID: 15077190
[TBL] [Abstract][Full Text] [Related]
12. Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study.
Rakha EA; Teoh TK; Lee AH; Nolan CC; Ellis IO; Green AR
Histopathology; 2013 Apr; 62(5):695-701. PubMed ID: 23347178
[TBL] [Abstract][Full Text] [Related]
13. The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast.
Dabbs DJ; Kaplai M; Chivukula M; Kanbour A; Kanbour-Shakir A; Carter GJ
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):260-6. PubMed ID: 17721269
[TBL] [Abstract][Full Text] [Related]
14. Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival.
Nakopoulou L; Gakiopoulou-Givalou H; Karayiannakis AJ; Giannopoulou I; Keramopoulos A; Davaris P; Pignatelli M
Histopathology; 2002 Jun; 40(6):536-46. PubMed ID: 12047765
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
Wahed A; Connelly J; Reese T
Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
[TBL] [Abstract][Full Text] [Related]
16. The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysis.
Suryadevara A; Paruchuri LP; Banisaeed N; Dunnington G; Rao KA
World J Surg Oncol; 2010 Jun; 8():51. PubMed ID: 20565965
[TBL] [Abstract][Full Text] [Related]
17. [Expression of Twist, E-cadherin and N-cadherin in breast carcinoma and their clinical significance].
Ma YH; Wang K; Li L; Lu ZH; Chen J
Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):5-9. PubMed ID: 20388391
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.
Mastracci TL; Tjan S; Bane AL; O'Malley FP; Andrulis IL
Mod Pathol; 2005 Jun; 18(6):741-51. PubMed ID: 15696125
[TBL] [Abstract][Full Text] [Related]
19. [Invasive lobular carcinoma of basal-like subtype of breast: a clinicopathologic analysis].
Zhang LY; Gao LX; Liu G; Yang GZ; Cheng J; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):599-603. PubMed ID: 24314245
[TBL] [Abstract][Full Text] [Related]
20. [E-cadherin associated protein expression and its significance in invasive lobular carcinoma and invasive ductal carcinoma of breast].
Han A; Xiong M; Li Z; Liang Y
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):27-30. PubMed ID: 11866953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
